Immunovant Funding History

Since Immunovant was founded in 2018, it has participated in 6 rounds of funding. In total Immunovant has raised $1.3B. Immunovant's last funding round was on Jan 2025 for a total of $450.0M.

Immunovant Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Post-IPO Equity
Jan 2025
$450M
__
Private Placement
Oct 2023
$492.1M
__
Post-IPO Equity
Oct 2022
$75M
__
Corporate Round
Aug 2021
$200M
1
IPO
Dec 2019
--
__

Immunovant Investors

INVESTOR

ROUND

FUNDING DATE

Corporate Round
Aug 2021
Equity
Oct 2019
Equity
Oct 2019
Equity
Oct 2019
Immunovant has 4 investors, including Roivant Sciences, RTW Investments and BVF Partners. The latest investment occurred in Jan 2025.